<DOC>
	<DOCNO>NCT00549913</DOCNO>
	<brief_summary>This first-in-human , dose escalation clinical study evaluate feasibility , safety , tolerability 3 different dos immunoselected , culture-expanded , nucleated , allogeneic MPCs ( NeoFuse ) combine MasterGraft Resorbable Ceramic Granules ( Medtronic Sofamor Danek USA , Inc. ) compare autograft patient require posterior lumbar interbody fusion NuVasive 's radiolucent PEEK OPTIMA cage ( use autologous bone graft material ) 1 2 level posterolateral lumbar fusion surgery instrumentation . The instrumentation use study Monarch® 5.50 mm Spine System ( DePuy ) .</brief_summary>
	<brief_title>Study 3 Doses NeoFuse Combined With MasterGraft Granules Subjects Requiring Posterolateral Lumbar Fusion ( PLF )</brief_title>
	<detailed_description>This prospective , single center , randomize , open-label control Phase 1b/2a study design evaluate safety preliminary efficacy MPCs combine MasterGraft Granules compare use autologous bone graft posterolateral fusion site subject require interbody fusion combination instrument 1 2 level PLF procedure . All subject study undergo 1 2-level ( 2 3 vertebra ) interbody fusion without use investigational product . In addition interbody fusion procedure , subject undergo instrumented posterolateral fusion . NeoFuse plus MasterGraft Granules one three dos autograft implant posterolateral lumbar fusion site ( ) . After screen surgical visit , subject evaluate clinically radiographically within 3 day 30 day surgery , 3 , 6 , 12 month surgery . Subjects evaluate 24 36 month surgery safety .</detailed_description>
	<mesh_term>Spondylolisthesis</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>1 . Men woman ≥ 18 year age . 2 . Have document symptomatic diagnosis DDD L1S1 without stenosis without include Grade II degenerative spondylolisthesis . 3 . May also coexistent spinal foraminal stenosis confirm MRI CT evaluation . 4 . Must clinical symptom neurogenic claudication . 5 . Must fail 6 month nonoperative management . 6 . Must candidate lumbar interbody fusion combination posterolateral lumbar fusion use autograft iliac crest require 1 2level fusion adjacent vertebral level L1 S1 . 7 . Must stable screening electrocardiogram ( ECG ) , determine investigator would preclude surgery . 1 . Is pregnant breastfeeding . 2 . Has Grade III great spondylolisthesis . 3 . Has undergoing revision prior fusion involve level . 4 . Has history hypersensitivity anaphylactic reaction murine bovine product , dimethyl sulfoxide ( DMSO ) , titanium . 5 . Has MRI CT show great 50 % anterior translocation cranial vertebral body great 20 degree angular motion listhesis segment . 6 . Has history active malignancy last 5 year , basal cell carcinoma . 7 . Has osteoporosis define dual energy xray absorptiometry ( DXA T ) score ≤ 3.5 history fragility fracture significant bone disease contraindicate use spinal instrumentation . Note : subject screen use Simple Calculated Osteoporosis Risk Evaluation ( SCORE ) osteoporosis questionnaire . 8 . Has history Paget 's disease spine , osteomalacia , metabolic bone disease . 9 . Has history prior radiotherapy involved area . 10 . Has receive systemic corticosteroid dose equivalent prednisone &gt; 10 mg/day within 14 day prior study procedure . 11 . Has receive systemic nonsteroidal antiinflammatory drug ( NSAIDS ) within 48 hour prior study procedure , unwilling refrain NSAIDS first 6 month follow procedure . 12 . Has positive screen human immunodeficiency virus ( HIV ) antibody . 13 . Has treatment investigational therapy administer within 6 month implantation surgery . . 14 . Is prior recipient allogeneic stem cell/progenitor cell therapy . 15 . Has body mass index ( BMI ) &gt; 3.5 16 . Has 20 % great antihuman leukocyte antigen ( HLA ) antibody titer and/or antibody specificity donor HLA antigen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>adjacent vertebral level L1 S1</keyword>
</DOC>